{
  "success": true,
  "enriched": 43,
  "total_entities": 510,
  "by_type": {
    "StudyArm": 2,
    "EligibilityCriterion": 33,
    "Objective": 4,
    "Endpoint": 4
  },
  "enriched_items": [
    {
      "type": "StudyArm",
      "name": "LY900018 3 mg (Nasal Glucagon)",
      "arm_type": "Experimental Arm",
      "nci_code": "C174266"
    },
    {
      "type": "StudyArm",
      "name": "IMG 1 mg (Intramuscular Glucagon)",
      "arm_type": "Active Comparator Arm",
      "nci_code": "C174267"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Diabetes diagnosis and insulin therapy",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Male contraception requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Female contraception and pregnancy requi",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Age requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Body mass index requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Hemoglobin A1c requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Clinical laboratory test results",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Venous access requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Reliability and availability",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Informed consent",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Investigative site personnel exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Lilly employees exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Current clinical trial enrollment exclus",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Recent clinical trial participation excl",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Previous LY900018 exposure exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Allergies or sensitivity exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "ECG abnormality exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Unstable insulin regimen or blood glucos",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "High insulin dose exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Poorly controlled hypertension exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Pheochromocytoma or insulinoma history e",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Severe hypoglycemia or loss of conscious",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Epilepsy or seizure disorder history exc",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Significant medical disorders exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Psychiatric disorders exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Drug abuse exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "HIV infection exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Hepatitis C exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Hepatitis B exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Syphilis exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Lactating women exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Prohibited medications exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Blood donation exclusion",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "Objective",
      "name": "Primary Efficacy Objective",
      "level": "Trial Primary Objective",
      "nci_code": "C85826"
    },
    {
      "type": "Objective",
      "name": "Safety and Tolerability Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Pharmacokinetic Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Pharmacodynamic Objective",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Endpoint",
      "name": "Treatment Success Rate",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Safety and Tolerability Endpoints",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Pharmacokinetic Parameters",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Pharmacodynamic Parameters",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    }
  ],
  "cache_stats": {
    "total_entries": 50,
    "fresh_entries": 50,
    "stale_entries": 0,
    "cache_file": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\core\\evs_cache\\nci_codes.json"
  }
}